Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer

Science Signaling

Volumn 8, Issue 388, 2015, Pages

  Foley, Kelly ^a,b   Rucki, Agnieszka A ^a,b   Xiao, Qian ^a,b   Zhou, Donger ^a,b   Leubner, Ashley ^a,b   Mo, Guanglan ^a,b   Kleponis, Jennifer ^a,b   Wu, Annie A ^a,b   Sharma, Rajni ^b   Jiang, Qingguang ^b,d   Anders, Robert A ^a,b   Iacobuzio Donahue, Christine A ^a,b,e   Hajjar, Katherine A ^c   Maitra, Anirban ^a,b,f   Jaffee, Elizabeth M ^a,b   Zheng, Lei ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 2; PLEXIN; SEMAPHORIN; SEMAPHORIN 3D; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; NERVE PROTEIN; PLXND1 PROTEIN, MOUSE; PROTEIN BINDING; SEMA 3D PROTEIN, MOUSE;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CANCER PROGNOSIS; CELL CULTURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNOPRECIPITATION; METASTASIS POTENTIAL; MOUSE; NERVE FIBER; NONHUMAN; NULL CELL; PANCREAS CANCER; PANCREAS TUMOR; PRECANCER; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; RECURRENCE FREE SURVIVAL; SIGNAL TRANSDUCTION; SURVIVAL; 129 MOUSE; ANIMAL; C57BL MOUSE; CLASSIFICATION; FLUORESCENCE MICROSCOPY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; METASTASIS; PANCREAS CARCINOMA; PATHOLOGY; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SURVIVAL ANALYSIS; TRANSGENIC MOUSE; TUMOR CELL CULTURE; WESTERN BLOTTING;

MUS; MUS MUSCULUS;

ANIMALS; ANNEXIN A2; AUTOCRINE COMMUNICATION; BLOTTING, WESTERN; CARCINOMA, PANCREATIC DUCTAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE GLYCOPROTEINS; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; NEOPLASM METASTASIS; NERVE TISSUE PROTEINS; PANCREATIC NEOPLASMS; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SEMAPHORINS; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 84938851607     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.aaa5823     Document Type: Article

References (42)

1. R. Siegel, J. Ma, Z. Zou, A. Jemal, Cancer statistics, 2014. CA Cancer J. Clin. 64, 9-29 (2014).
2. D. Li, K. Xie, R. Wolff, J. L. Abbruzzese, Pancreatic cancer. Lancet 363, 1049-1057 (2004).
3. E. Lutz, C. J. Yeo, K. D. Lillemoe, B. Biedrzycki, B. Kobrin, J. Herman, E. Sugar, S. Piantadosi, J. L. Cameron, S. Solt, B. Onners, I. Tartakovsky, M. Choi, R. Sharma, P. B. Illei, R. H. Hruban, R. A. Abrams, D. Le, E. Jaffee, D. Laheru, A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A phase II trial of safety, efficacy, and immune activation. Ann. Surg. 253, 328-335 (2011).
4. L. Zheng, K. Foley, L. Huang, A. Leubner, G. Mo, K. Olino, B. H. Edil, M. Mizuma, R. Sharma, D. T. Le, R. A. Anders, P. B. Illei, J. E. Van Eyk, A. Maitra, D. Laheru, E. M. Jaffee, Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. PLOS One 6, e19390 (2011).
5. A. V. Biankin, N. Waddell, K. S. Kassahn, M. C. Gingras, L. B. Muthuswamy, A. L. Johns, D. K. Miller, P. J. Wilson, A. M. Patch, J. Wu, D. K. Chang, M. J. Cowley, B. B. Gardiner, S. Song, I. Harliwong, S. Idrisoglu, C. Nourse, E. Nourbakhsh, S. Manning, S. Wani, M. Gongora, M. Pajic, C. J. Scarlett, A. J. Gill, A. V. Pinho, I. Rooman, M. Anderson, O. Holmes, C. Leonard, D. Taylor, S. Wood, Q. Xu, K. Nones, J. L. Fink, A. Christ, T. Bruxner, N. Cloonan, G. Kolle, F. Newell, M. Pinese, R. S. Mead, J. L. Humphris, W. Kaplan, M. D. Jones, E. K. Colvin, A. M. Nagrial, E. S. Humphrey, A. Chou, V. T. Chin, L. A. Chantrill, A. Mawson, J. S. Samra, J. G. Kench, J. A. Lovell, R. J. Daly, N. D. Merrett, C. Toon, K. Epari, N. Q. Nguyen, A. Barbour, N. Zeps, I. Australian Pancreatic Cancer Genome, N. Kakkar, F. Zhao, Y. Q. Wu, M. Wang, D. M. Muzny, W. E. Fisher, F. C. Brunicardi, S. E. Hodges, J. G. Reid, J. Drummond, K. Chang, Y. Han, L. R. Lewis, H. Dinh, C. J. Buhay, T. Beck, L. Timms, M. Sam, K. Begley, A. Brown, D. Pai, A. Panchal, N. Buchner, R. De Borja, R. E. Denroche, C. K. Yung, S. Serra, N. Onetto, D. Mukhopadhyay, M. S. Tsao, P. A. Shaw, G. M. Petersen, S. Gallinger, R. H. Hruban, A. Maitra, C. A. Iacobuzio-Donahue, R. D. Schulick, C. L. Wolfgang, R. A. Morgan, R. T. Lawlor, P. Capelli, V. Corbo, M. Scardoni, G. Tortora, M. A. Tempero, K. M. Mann, N. A. Jenkins, P. A. Perez-Mancera, D. J. Adams, D. A. Largaespada, L. F. Wessels, A. G. Rust, L. D. Stein, D. A. Tuveson, N. G. Copeland, E. A. Musgrove, A. Scarpa, J. R. Eshleman, T. J. Hudson, R. L. Sutherland, D. A. Wheeler, J. V. Pearson, J. D. McPherson, R. A. Gibbs, S. M. Grimmond, Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399-405 (2012).
6. S. Jones, X. Zhang, D. W. Parsons, J. C. Lin, R. J. Leary, P. Angenendt, P. Mankoo, H. Carter, H. Kamiyama, A. Jimeno, S. M. Hong, B. Fu, M. T. Lin, E. S. Calhoun, M. Kamiyama, K. Walter, T. Nikolskaya, Y. Nikolsky, J. Hartigan, D. R. Smith, M. Hidalgo, S. D. Leach, A. P. Klein, E. M. Jaffee, M. Goggins, A. Maitra, C. Iacobuzio-Donahue, J. R. Eshleman, S. E. Kern, R. H. Hruban, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V. E. Velculescu, K. W. Kinzler, Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801-1806 (2008).
7. M. W. Müller, N. A. Giese, J. M. Swiercz, G. O. Ceyhan, I. Esposito, U. Hinz, P. Büchler, T. Giese, M. W. Büchler, S. Offermanns, H. Friess, Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer. Int. J. Cancer 121, 2421-2433 (2007).
8. I. Roodink, G. Kats, L. van Kempen, M. Grunberg, C. Maass, K. Verrijp, J. Raats, W. Leenders, Semaphorin 3E expression correlates inversely with plexin D1 during tumor progression. Am. J. Pathol. 173, 1873-1881 (2008).
9. M. A. Shalaby, L. Hampson, A. Oliver, I. Hampson, Plexin D1: New potential biomarker for cervical cancer. J. Immunoassay Immunochem. 33, 223-233 (2012).
10. A. Casazza, V. Finisguerra, L. Capparuccia, A. Camperi, J. M. Swiercz, S. Rizzolio, C. Rolny, C. Christensen, A. Bertotti, I. Sarotto, M. Risio, L. Trusolino, J. Weitz, M. Schneider, M. Mazzone, P. M. Comoglio, L. Tamagnone, Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice. J. Clin. Invest. 120, 2684-2698 (2010).
11. J. Luchino, M. Hocine, M. C. Amoureux, B. Gibert, A. Bemet, A. Royet, I. Treilleux, P. Lécine, J. P. Borg, P. Mehlen, S. Chauvet, F. Mann, Semaphorin 3E suppresses tumor cell death triggered by the plexin D1 dependence receptor in metastatic breast cancers. Cancer Cell 24, 673-685 (2013).
12. P. Mehlen, C. Delloye-Bourgeois, A. Chédotal, Novel roles for Slits and netrins: Axon guidance cues as anticancer targets? Nat. Rev. Cancer 11, 188-197 (2011).
13. T. Worzfeld, S. Offermanns, Semaphorins and plexins as therapeutic targets. Nat. Rev. Drug Discov. 13, 603-621 (2014).
14. M. Rehman, L. Tamagnone, Semaphorins in cancer: Biological mechanisms and therapeutic approaches. Semin. Cell Dev. Biol. 24, 179-189 (2013).
15. C. H. Tseng, K. D. Murray, M. F. Jou, S. M. Hsu, H. J. Cheng, P. H. Huang, Sema3E/plexin-D1 mediated epithelial-to-mesenchymal transition in ovarian endometrioid cancer. PLOS One 6, e19396 (2011).
16. G12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7, 469-483 (2005).
17. Q. Ling, A. T. Jacovina, A. Deora, M. Febbraio, R. Simantov, R. L. Silverstein, B. Hempstead, W. H. Mark, K. A. Hajjar, Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J. Clin. Invest. 113, 38-48 (2004).
18. B. Huang, A. B. Deora, K. L. He, K. Chen, G. Sui, A. T. Jacovina, D. Almeida, P. Hong, P. Burgman, K. A. Hajjar, Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice. Blood 118, 2918-2929 (2011).
19. K. C. Soares, K. Foley, K. Olino, A. Leubner, S. C. Mayo, A. Jain, E. Jaffee, R. D. Schulick, K. Yoshimura, B. Edil, L. Zheng, A preclinical murine model of hepatic metastases. J. Vis. Exp. 91, 51677 (2014).
20. L. Tamagnone, P. M. Comoglio, To move or not to move? Semaphorin signalling in cell migration. EMBO Rep. 5, 356-361 (2004).
21. V. Gerke, S. E. Moss, Annexins: From structure to function. Physiol. Rev. 82, 331-371 (2002).
22. Y. Biener, R. Feinstein, M. Mayak, Y. Kaburagi, T. Kadowaki, Y. Zick, Annexin II is a novel player in insulin signal transduction. Possible association between annexin II phosphorylation and insulin receptor internalization. J. Biol. Chem. 271, 29489-29496 (1996).
23. D. S. Drust, C. E. Creutz, Aggregation of chromaffin granules by calpactin at micromolar levels of calcium. Nature 331, 88-91 (1988).
24. 2+- regulated-phospholipid binding protein. Biosci. Rep. 7, 289-298 (1987).
25. C. Gu, Y. Yoshida, J. Livet, D. V. Reimert, F. Mann, J. Merte, C. E. Henderson, T. M. Jessell, A. L. Kolodkin, D. D. Ginty, Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science 307, 265-268 (2005).
26. L. Tamagnone, P. M. Comoglio, Signalling by semaphorin receptors: Cell guidance and beyond. Trends Cell Biol. 10, 377-383 (2000).
27. Y. S. Oh, P. Gao, K. W. Lee, I. Ceglia, J. S. Seo, X. Zhang, J. H. Ahn, B. T. Chait, D. J. Patel, Y. Kim, P. Greengard, SMARCA3, a chromatin-remodeling factor, is required for p11-dependent antidepressant action. Cell 152, 831-843 (2013).
28. A. J. Minn, G. P. Gupta, P. M. Siegel, P. D. Bos, W. Shu, D. D. Giri, A. Viale, A. B. Olshen, W. L. Gerald, J. Massagué, Genes that mediate breast cancer metastasis to lung. Nature 436, 518-524 (2005).
29. D. I. Rodenhiser, J. D. Andrews, T. A. Vandenberg, A. F. Chambers, Gene signatures of breast cancer progression and metastasis. Breast Cancer Res. 13, 201 (2011).
30. K. Zylbersztejn, M. Petkovic, A. Burgo, M. Deck, S. Garel, S. Marcos, E. Bloch-Gallego, F. Nothias, G. Serini, D. Bagnard, T. Binz, T. Galli, The vesicular SNARE Synaptobrevin is required for Semaphorin 3A axonal repulsion. J. Cell Biol. 196, 37-46 (2012).
31. C. J. Merrifield, U. Rescher, W. Almers, J. Proust, V. Gerke, A. S. Sechi, S. E. Moss, Annexin 2 has an essential role in actin-based macropinocytic rocketing. Curr. Biol. 11, 1136-1141 (2001).
32. U. Yazdani, J. R. Terman, The semaphorins. Genome Biol. 7, 211 (2006).
33. E.Pecho-Vrieseling, M. Sigrist, Y. Yoshida, T. M. Jessell, S. Arber, Specificity of sensory-motor connections encoded by Sema3e-Plxnd1 recognition. Nature 459, 842-846 (2009).
34. A. A. Bapat, G. Hostetter, D. D. Von Hoff, H. Han, Perineural invasion and associated pain in pancreatic cancer. Nat. Rev. Cancer 11, 695-707 (2011).
35. H. Takahashi, H. Ohigashi, O. Ishikawa, K. Gotoh, T. Yamada, S. Nagata, Y. Tomita, H. Eguchi, Y. Doki, M. Yano, Perineural invasion and lymph node involvement as indicators of surgical outcome and pattern of recurrence in the setting of preoperative gemcitabine-based chemoradiation therapy for resectable pancreatic cancer. Ann. Surg. 255, 95-102 (2012).
36. K. M. Bever, E. A. Sugar, E. Bigelow, R. Sharma, D. Laheru, C. L. Wolfgang, E. M. Jaffee, R. A. Anders, A. De Jesus-Acosta, L. Zheng, The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapy. HPB 17, 292-298 (2015).
37. C. A. Iacobuzio-Donahue, B. Fu, S. Yachida, M. Luo, H. Abe, C. M. Henderson, F. Vilardell, Z. Wang, J. W. Keller, P. Banerjee, J. M. Herman, J. L. Cameron, C. J. Yeo, M. K. Halushka, J. R. Eshleman, M. Raben, A. P. Klein, R. H. Hruban, M. Hidalgo, D. Laheru, DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J. Clin. Oncol. 27, 1806-1813 (2009).
38. P. A. Pérez-Mancera, A. G. Rust, L. van der Weyden, G. Kristiansen, A. Li, A. L. Sarver, K. A. Silverstein, R. Grützmann, D. Aust, P. Rümmele, T. Knösel, C. Herd, D. L. Stemple, R. Kettleborough, J. A. Brosnan, A. Li, R. Morgan, S. Knight, J. Yu, S. Stegeman, L. S. Collier, J. J. ten Hoeve, J. de Ridder, A. P. Klein, M. Goggins, R. H. Hruban, D. K. Chang, A. V. Biankin, S. M. Grimmond, Australian Pancreatic Cancer Genome; L. F. Wessels, S. A. Wood, C. A. Iacobuzio-Donahue, C. Pilarsky, D. A. Largaespada, D. J. Adams, D. A. Tuveson, The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature 486, 266-270 (2012).
39. A. Jain, J. E. Slansky, L. C. Matey, H. E. Allen, D. M. Pardoll, R. D. Schulick, Synergistic effect of a granulocyte-macrophage colony-stimulating factor-transduced tumor vaccine and systemic interleukin-2 in the treatment of murine colorectal cancer hepatic metastases. Ann. Surg. Oncol. 10,810-820 (2003).
40. T. H. Corbett, B. J. Roberts, W. R. Leopold, J. C. Peckham, L. J. Wilkoff, D. P. Griswold Jr., F. M. Schabel Jr., Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. Cancer Res. 44, 717-726 (1984).
41. X. Zhou, Y. Cui, X. Huang, Z. Yu, A. M. Thomas, Z. Ye, D. M. Pardoll, E. M. Jaffee, L. Cheng, Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cells. Hum. Gene Ther. 14, 1089-1105 (2003).
42. J. Ruan, M. Luo, C. Wang, L. Fan, S. N. Yang, M. Cardenas, H. Geng, J.P. Leonard, A. Melnick, L. Cerchietti, K. A. Hajjar, Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes. Blood 121, 5192-5202 (2013).